Effectiveness and efficiency of targeted intra-operative single dose radiotherapy for breast cancer patients confirmed

New long-term results from the international TARGIT-A breast cancer study, based on ZEISS technology, have been published1 JENA/ GERMANY, August 26, 2020 Use of targeted intra-operative radiotherapy (TARGIT), as a single dose – with ZEISS INTRABEAM – directly after removal of a tumor, confirmed as non-inferior, when compared with external beam radiotherapy (EBRT). Within the … Skaityti toliau